IRINOTECAN THYMOORGAN
IRINOTECAN TRHYDRATE CHLORHYDRATE
Public price
1,58 MAD
Active substance
IRINOTECAN TRHYDRATE CHLORHYDRATE
Laboratory
PROMOPHARM
What is this medicine?
IRINOTECAN THYMOORGAN: This substance is an antineoplastic treatment used in oncology. It is reserved for specialist supervised protocols.
Verified summary
IRINOTECAN TRHYDRATE CHLORHYDRATE, SOLUTION A DILUER POUR PERFUSION, 300 MG / 15 ML, BOITE DE 1 FLACON DE 15 ML
Common uses
Common uses: solid or haematological cancers depending on the molecule, stage, protocol, and oncology-team decision. General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Oncology - antineoplastic
Laboratory
PROMOPHARM
Hospital price
1,31 MAD
Strength
300 MG / 15 ML
Form
SOLUTION A DILUER POUR PERFUSION
Presentation
BOITE DE 1 FLACON DE 15 ML
Commercial status
Commercialisé AO
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 1,58 MAD
Available presentations and strengths
Medicines with the same active substance
IRINOTECAN RANBAXY
100 MG / 5 ML · BOITE DE 1 FLACON DE 5 ML
1,09 MAD
IRINOTECAN ZENITH
100 MG / 5 ML · BOITE DE 1 FLACON DE 5 ML
1,19 MAD
IMTUS
100 MG / 5 ML · BOITE D'UN FLACON DE 5 ML
1,31 MAD
IRINOTECAN VIATRIS
20 MG / ML · BOITE DE 1 FLACON DE 15 ML
1,42 MAD
IRINOTECAN VIATRIS
20 MG / ML · BOITE DE 1 FLACON DE 2 ML
450,00 MAD
IRINOTECAN ZENITH
40 MG / 2 ML · BOITE DE 1 FLACON DE 5 ML
499,00 MAD
IRINOTECAN RANBAXY
40 MG / 2 ML · BOITE DE 1 FLACON DE 2 ML
505,00 MAD
IMTUS
40 MG / 2 ML · BOITE D'UN FLACON DE 2 ML
520,00 MAD
IRINOTECAN VIATRIS
20 MG / ML · BOITE DE 1 FLACON DE 5 ML
975,00 MAD